Caladrius Biosciences

NASDAQ

CLBS

- - -%

Today share price

USA

Sector: Healthcare Industry: Biotechnology

Get access
to the rating of Finrange stocks

With this tariff you will be able to use the service without restrictions, all information will be available

Get 7 days free

274.82M

179.85M

1.05

60.53M

Indicator	Company	Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months. More	-11.18	27.22
P/BV (LTM) Shows the ratio of the market price of the share to the current book value. More	2.99	3.54
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months. More	-6.63	9.69
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt. More	3.50	-0.16
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months. More	-29.82	13.82

1.12$ 3.05$

Min Max

Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; OLOGO, a regenerative medicine advanced therapy for treating no-option refractory disabling angina; CLBS16 that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Address:

110 Allen Road, Basking Ridge, NJ, United States, 07920

Company name:

Caladrius Biosciences

Issuer ticker: CLBS

ISIN: US1280582032

Country: USA

Exchange: NASDAQ

Currency: $

IPO date: 1999-03-01

Sector: Healthcare

Industry: Biotechnology

Site:

https://www.caladrius.com

On which stock exchange are Caladrius Biosciences (CLBS) stocks traded?

Caladrius Biosciences (CLBS) stocks are traded on NASDAQ.

What is the ticker of Caladrius Biosciences stocks (CLBS)?

The stock ticker of Caladrius Biosciences’s stocks or in other words, the code is CLBS. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Caladrius Biosciences (CLBS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Caladrius Biosciences (CLBS) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Caladrius Biosciences (CLBS) stocks traded?

Caladrius Biosciences (CLBS) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Caladrius Biosciences (CLBS) stocks today?

The current price of Caladrius Biosciences stocks on 11.05.2024 is dollars. per share.

What is the dynamics of Caladrius Biosciences (CLBS) stocks from the beginning of the year?

Caladrius Biosciences (CLBS) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Caladrius Biosciences (CLBS) stocks increase in мае 2024?

This month Caladrius Biosciences (CLBS) quotes have increased by 0% to dollars. per share.

How much are Caladrius Biosciences (CLBS) stocks worth?

Today, on October, 11.05.2024 Caladrius Biosciences’s (CLBS) stocks cost dollars..

What is the market capitalization of Caladrius Biosciences (CLBS)?

Capitalization is the market value of Caladrius Biosciences (CLBS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 11.05.2024, the market capitalization of Caladrius Biosciences (CLBS) is estimated at about 274819820 dollars.

Caladrius Biosciences

Rating Finrange

Upcoming events Caladrius Biosciences

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Caladrius Biosciences

Stock analysis Caladrius Biosciences

Price change Caladrius Biosciences per year

Summary analysis Caladrius Biosciences

Shareholder structure Caladrius Biosciences

Revenue and net income Caladrius Biosciences

Stock news Caladrius Biosciences